Venous thromboembolism Trials in Silkeborg, Denmark
Conditions / Venous thromboembolism / Silkeborg, Denmark
Research into Venous thromboembolism spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01225822 | BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery | COMPLETED | PHASE2 |
| NCT00362232 | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. | COMPLETED | PHASE3 |
| NCT00902928 | A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery | COMPLETED | PHASE2/PHASE3 |
| NCT00329628 | Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin | COMPLETED | PHASE3 |
| NCT00332020 | Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | COMPLETED | PHASE3 |
| NCT00119457 | Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) | COMPLETED | PHASE2 |
| NCT00657150 | Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty | COMPLETED | PHASE3 |
| NCT00398905 | Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | COMPLETED | PHASE2 |
| NCT00361894 | Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement. | COMPLETED | PHASE3 |
| NCT00396786 | Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement | COMPLETED | PHASE2 |